Advertisement
Original Communications| Volume 129, ISSUE 6, P704-713, June 2001

Download started.

Ok

Clinical significance of lymph node micrometastasis in gallbladder carcinoma

      Abstract

      Background. This retrospective study was intended to define the clinical significance of lymph node micrometastasis in gallbladder carcinoma. Methods. A total of 1136 regional lymph nodes taken from 63 consecutive patients undergoing radical resection were examined histologically. Micrometastasis was defined as a metastasis missed on routine histologic examination with hematoxylin-and-eosin but detected by immunohistochemical examination with an antibody against cytokeratins 8 and 18. Results. None of 9 patients (0%) with pT1 disease and 19 of 54 patients (35%) with pT2-4 disease had nodal micrometastases. Univariate analysis identified nodal micrometastasis, type of radical resection, M classification, pT classification, perineural invasion, pTNM stage, timing of radical resection, lymphatic vessel invasion, and pN classification as significant variables. Multivariate analysis revealed that nodal micrometastasis (P =.0003) and type of radical resection (P=.0044) were independent prognostic factors. Nodal micrometastasis affected survival adversely, despite the absence (P=.0002) or presence (P <.0001) of overt nodal metastasis. Nodal micrometastasis correlated significantly with invasive characteristics: lymphatic vessel invasion, perineural invasion, and distant metastasis. Conclusions. Lymph node micrometastasis is the strongest independent predictor of worse survival regardless of the overt nodal status and may indicate aggressive tumor biology among patients undergoing curative resection for gallbladder carcinoma. (Surgery 2001;129:704-13.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Shirai Y
        • Yoshida K
        • Tsukada K
        • Muto T
        • Watanabe H.
        Radical surgery for gallbladder carcinoma. Long-term results.
        Ann Surg. 1992; 216: 565-568
        • Tsukada K
        • Hatakeyama K
        • Kurosaki I
        • Uchida K
        • Shirai Y
        • Muto T
        • et al.
        Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage.
        Surgery. 1996; 120: 816-822
        • Yamaguchi K
        • Chijiiwa K
        • Saiki S
        • Nishihara K
        • Takashima M
        • Kawakami K
        • et al.
        Retrospective analysis of 70 operations for gallbladder carcinoma.
        Br J Surg. 1997; 84: 200-204
        • McGuckin MA
        • Cummings MC
        • Walsh MD
        • Hohn BG
        • Bennett IC
        • Wright RG
        Occult axillary node metastases in breast cancer: their detection and prognostic significance.
        Br J Cancer. 1996; 73: 88-95
        • Lachman MF
        • Ricci Jr, A
        • Pedersen CA
        • Cartun RW
        • Strumpf KB
        Detection of occult metastatic lobular carcinoma in axillary lymph nodes using anticytokeratin monoclonal antibodies.
        Conn Med. 1992; 56: 65-68
        • Maruyama R
        • Sugio K
        • Mitsudomi T
        • Saitoh G
        • Ishida T
        • Sugimachi K.
        Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer.
        J Thorac Cardiovasc Surg. 1997; 114: 535-543
        • Chen ZL
        • Perez S
        • Holmes EC
        • Wang HJ
        • Coulson WF
        • Wen DR
        • et al.
        Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma.
        J Natl Cancer Inst. 1993; 85: 493-498
        • Izbicki JR
        • Hosch SB
        • Pichlmeier U
        • Rehders A
        • Busch C
        • Niendorf A
        • et al.
        Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer.
        N Engl J Med. 1997; 337: 1188-1194
        • Glickman JN
        • Torres C
        • Wang HH
        • Turner JR
        • Shahsafaei A
        • Richards WG
        • et al.
        The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
        Cancer. 1999; 85: 769-778
        • Ishida K
        • Katsuyama T
        • Sugiyama A
        • Kawasaki S.
        Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas.
        Cancer. 1997; 79: 1069-1076
        • Maehara Y
        • Oshiro T
        • Endo K
        • Baba H
        • Oda S
        • Ichiyoshi Y
        • et al.
        Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence.
        Surgery. 1996; 119: 397-402
        • Davidson BR
        • Sams VR
        • Styles J
        • Deane C
        • Boulos PB
        Detection of occult nodal metastases in patients with colorectal carcinoma.
        Cancer. 1990; 65: 967-970
        • Jeffers MD
        • O'Dowd GM
        • Mulcahy H
        • Stagg M
        • O'Donoghue DP
        • Toner M.
        The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma.
        J Pathol. 1994; 172: 183-187
        • Cutait R
        • Alves VA
        • Lopes LC
        • Cutait DE
        • Borges JL
        • Singer J
        • et al.
        Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins.
        Dis Colon Rectum. 1991; 34: 917-920
        • Öberg Å
        • Stenling R
        • Tavelin B
        • Lindmark G.
        Are lymph node micrometastases of any clinical significance in Dukes' stages A and B colorectal cancer?.
        Dis Colon Rectum. 1998; 41: 1244-1249
        • Adell G
        • Boeryd B
        • Frånlund B
        • Sjödahl R
        • Håkansson L.
        Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study.
        Eur J Surg. 1996; 162: 637-642
        • Greenson JK
        • Isenhart CE
        • Rice R
        • Mojzisik C
        • Houchens D
        • Martin Jr, EW
        Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.
        Cancer. 1994; 73: 563-569
        • Sasaki M
        • Watanabe H
        • Jass JR
        • Ajioka Y
        • Kobayashi M
        • Hatakeyama K.
        Immunoperoxidase staining for cytokeratins 8 and 18 is very sensitive for detection of occult node metastasis of colorectal cancer: a comparison with genetic analysis of K-ras.
        Histopathology. 1998; 32: 199-208
        • Sasaki M
        • Watanabe H
        • Jass JR
        • Ajioka Y
        • Kobayashi M
        • Matsuda K
        • et al.
        Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in “node-negative” colorectal cancer.
        J Gastroenterol. 1997; 32: 758-764
        • Bertoglio S
        • Percivale P
        • Gambini C
        • Dicasa D
        • Meszaros P
        • Sciallero S
        • et al.
        Cytokeratin immunostaining reveals micrometastasis in negative hematoxylin-eosin lymph nodes of resected stage I-II (pT2-pT3) colorectal cancer.
        J Chemother. 1997; 9: 119-120
        • Yokoyama N
        • Shirai Y
        • Hatakeyama K.
        Immunohistochemical detection of lymph node micrometastases from gallbladder carcinoma using monoclonal anticytokeratin antibody.
        Cancer. 1999; 85: 1465-1469
        • Tajima Y
        • Tomioka T
        • Ikematsu Y
        • Ichinose K
        • Inoue K
        • Kanematsu T.
        Immunohistochemical demonstration of cytokeratin is useful for detecting micrometastatic foci from gallbladder carcinoma in regional lymph nodes.
        Jpn J Clin Oncol. 1999; 29: 425-428
      1. 5th ed. American Joint Committee on Cancer Staging Manual. JB Lippincott, Philadelphia1997
        • Shirai Y
        • Ohtani T
        • Tsukada K
        • Hatakeyama K.
        Combined pancreaticoduodenectomy and hepatectomy for patients with locally advanced gallbladder carcinoma. Long term results.
        Cancer. 1997; 80: 1904-1909
        • Tsukada K
        • Yoshida K
        • Aono T
        • Koyama S
        • Shirai Y
        • Uchida K
        • et al.
        Major hepatectomy and pancreaticoduodenectomy for advanced carcinoma of the biliary tract.
        Br J Surg. 1994; 81: 108-110
        • Ohtani T
        • Shirai Y
        • Tsukada K
        • Hatakeyama K
        • Muto T.
        Carcinoma of the gallbladder: CT evaluation of lymphatic spread.
        Radiology. 1993; 189: 875-880
        • Shirai Y
        • Ohtani T
        • Tsukada K
        • Hatakeyama K.
        Patterns of lymphatic spread of carcinoma of the ampulla of Vater.
        Br J Surg. 1997; 84: 1012-1016
        • Shirai Y
        • Yoshida K
        • Tsukada K
        • Muto T
        • Watanabe H.
        Early carcinoma of the gallbladder.
        Eur J Surg. 1992; 158: 545-548
        • Tsukada K
        • Kurosaki I
        • Uchida K
        • Shirai Y
        • Oohashi Y
        • Yokoyama N
        • et al.
        Lymph node spread from carcinoma of the gallbladder.
        Cancer. 1997; 80: 661-667
        • Chijiiwa K
        • Tanaka M.
        Indications for and limitations of extended cholecystectomy in the treatment of carcinoma of the gallbladder.
        Eur J Surg. 1996; 162: 211-216
        • Benoist S
        • Panis Y
        • Fagniez P.
        Long-term results after curative resection for carcinoma of the gallbladder.
        Am J Surg. 1998; 175: 118-122
        • Shirai Y
        • Yoshida K
        • Tsukada K
        • Ohtani T
        • Muto T.
        Identification of the regional lymphatic system of the gallbladder by vital staining.
        Br J Surg. 1992; 79: 659-662
        • Diel IJ
        • Kaufmann M
        • Goerner R
        • Costa SD
        • Kaul S
        • Bastert G.
        Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis.
        J Clin Oncol. 1992; 10: 1534-1539
        • Lindemann F
        • Schlimok G
        • Dirschedl P
        • Witte J
        • Riethmuller G.
        Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients.
        Lancet. 1992; 340: 685-689
        • Jauch KW
        • Heiss MM
        • Gruetzner U
        • Funke I
        • Pantel K
        • Babic R
        • et al.
        Prognostic significance of bone marrow micrometastases in patients with gastric cancer.
        J Clin Oncol. 1996; 14: 1810-1817
        • Giuliano AE
        • Dale PS
        • Turner RR
        • Morton DL
        • Evans SW
        • Krasne DL
        Improved axillary staging of breast cancer with sentinel lymphadenectomy.
        Ann Surg. 1995; 222: 394-401
        • Castro MP
        Efficacy of Gemcitabine in the treatment of patients with gallbladder carcinoma: a case report.
        Cancer. 1998; 82: 639-641
        • Gallardo J
        • Fodor M
        • Gamargo C
        • Orlandi L.
        Efficacy of gemcitabine in the treatment of patients with gallbladder carcinoma: a case report [letter].
        Cancer. 1998; 83: 2419-2420
        • Gebbia V
        • Majello E
        • Testa A
        • Pezzella G
        • Giuseppe S
        • Riccardi F
        • et al.
        Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M).
        Cancer. 1996; 78: 1300-1307
        • Shirai Y
        • Ohtani T
        • Tsukada K
        • Hatakeyama K.
        Lymph node recurrence of gallbladder carcinoma successfully managed by systemic chemotherapy with 5-fluorouracil and mitomysin C: report of a 5-year survivor.
        Eur J Surg Oncol. 1997; 23: 457-458
        • Kubota K
        • Bandai Y
        • Noie T
        • Ishizaki Y
        • Teruya M
        • Makuuchi M.
        How should polypoid lesions of the gallbladder be treated in the era of laparoscopic cholecystectomy?.
        Surgery. 1995; 117: 481-487